Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy

Document Type

Journal Article

Publisher

Lippincott Williams and Wilkins

Faculty

Faculty of Health, Engineering and Science

School

ECU Health and Wellness Institute

RAS ID

18766

Funders

National Health and Medical Research Council

Grant Number

NHMRC Number : 534409

Comments

Wall B.A., Galvao D.A., Fatehee N., Taaffe D.R., Spry N., Joseph D., & Newton R.U. (2014). Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy. Medicine and Science in Sports and Exercise, 46(12), 2210-2215. Available here

Abstract

Exercise is being increasingly established as a key adjuvant therapy in clinical oncology. As research has demonstrated the beneficial effect of exercise for cancer management, a growing number of patients with cancer are undertaking structured exercise programs.Purpose: This study aimed to determine the safety and feasibility of formal exercise testing in clinical settings as it is becoming increasingly used as a screening tool and for exercise prescription purposes.Methods: One hundred and twelve patients with prostate cancer undergoing androgen deprivation therapy (ADT) took part in a physician-supervised multistage maximal stress test (Bruce protocol). Sixty patients had been on ADT for (acute), whereas 52 had been on ADT for (chronic).Results: Of these men, 85% were able to meet the criteria for the attainment of VO2max, whereas three positive tests (3.2%) were observed. The three participants who recorded a positive stress test underwent further medical examination and were subsequently cleared of clinically significant cardiovascular disease. Apart from the relatively low VO2max (24.7 ± 6.0 mLIkg-1Imin-1, 10th-15th percentile), compared with normative data in healthy age-matched controls, the cardiovascular response to exercise was similar in this cancer population. Moreover, treatment duration did not seem to influence cardiovascular responses to exercise. This early evidence suggests that risk of adverse events during maximal exercise testing is relatively low in this population and certainly no higher than that in ages-matched, apparently healthy individuals.Conclusions: Maximal exercise testing was demonstrated to be feasible and safe, providing a direct assessment ofVO2max. The relatively low number of positive tests in this study suggests that the risk of adverse events is relatively low in this population and certainly no higher than that in age-matched, apparently healthy individuals.

DOI

10.1249/MSS.0000000000000353

Access Rights

free_to_read

Link to Full Text

Share

 
COinS